485 related articles for article (PubMed ID: 186692)
1. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
DeRubertis FR; Craven PA
Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
[TBL] [Abstract][Full Text] [Related]
2. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
Craven PA; Derubertis FR
Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
[TBL] [Abstract][Full Text] [Related]
3. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
DeRubertis FR; Craven P
Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
[TBL] [Abstract][Full Text] [Related]
4. The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.
DeRubertis FR; Chayoth R; Field JB
J Clin Invest; 1976 Mar; 57(3):641-9. PubMed ID: 175089
[TBL] [Abstract][Full Text] [Related]
5. Effects of reduced ATP concent on hepatic responses to glucagon.
DeRubertis FR; Craven P
Metabolism; 1976 Jan; 25(1):57-67. PubMed ID: 173976
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
Hickie RA
Adv Exp Med Biol; 1977 May 22-24; 92():451-88. PubMed ID: 24988
[No Abstract] [Full Text] [Related]
7. Cyclic nucleotide metabolism in solid tumor tissues.
Criss WE; Muganda P; Sahai A; Morris HP
Adv Exp Med Biol; 1977 May 22-24; 92():489-516. PubMed ID: 24989
[TBL] [Abstract][Full Text] [Related]
8. A study of cyclic nucleotide metabolism and the histology of rat liver during 3'-methyl-4-dimethylamino-azobenzene carcinogenesis. II. Cyclic AMP metabolism.
Boyd H; McAfee DA; Rubin JJ
Tissue Cell; 1978; 10(3):477-94. PubMed ID: 214895
[TBL] [Abstract][Full Text] [Related]
9. Hepatic adenylate cyclase and phosphodiesterase activity during acute ethionine intoxication.
Wong KH; Kisilevsky R
Exp Mol Pathol; 1984 Feb; 40(1):122-34. PubMed ID: 6319176
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
11. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
Chayoth R; Epstein SM; Field JB
Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
[No Abstract] [Full Text] [Related]
12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
13. Role of cyclic GMP in the mediation of circadian rhythmicity of the adenylate cyclase-cyclic AMP-phosphodiesterase system in Euglena.
Tong J; Edmunds LN
Biochem Pharmacol; 1993 May; 45(10):2087-91. PubMed ID: 8390260
[TBL] [Abstract][Full Text] [Related]
14. Studies on cyclic nucleotides in cancer. I. Adenylate guanylate cyclase and protein kinases in the prostatic sarcoma tissue.
Shima S; Kawashima Y; Hirai M; Kouyama H
Biochim Biophys Acta; 1976 Sep; 444(2):571-8. PubMed ID: 9148
[TBL] [Abstract][Full Text] [Related]
15. [The role of the components of the cyclic nucleotide system in N-nitrosodiethylamine-induced hepatic carcinogenesis in rats].
Antonenko SG; Berdinskikh NK; Mishnaevskaia EG
Eksp Onkol; 1990; 12(5):18-21. PubMed ID: 2171896
[TBL] [Abstract][Full Text] [Related]
16. [Concentration of cyclic nucleotides, activity of adenylate cyclase, 3',5'-AMP phosphodiesterase and guanylate cyclase in plasma membranes from liver and hepatomas of different degrees of malignancy].
Davydova SIa; Vetchinin SS
Vopr Med Khim; 1978; 24(5):652-7. PubMed ID: 30212
[TBL] [Abstract][Full Text] [Related]
17. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
[TBL] [Abstract][Full Text] [Related]
18. [Some features of cyclic adenosine monophosphate metabolism in mouse liver and hepatoma 22].
Solntseva TI; Belousova AK
Biokhimiia; 1977 Jul; 42(7):1331-7. PubMed ID: 20168
[TBL] [Abstract][Full Text] [Related]
19. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
20. Calcium-dependent regulation of guanosine 3',5'-monophosphate in renal cortex: effects of ionophore A23187 and tetracaine and evidence for independent control of adenosine 3',5'-monophosphate.
DeRubertis FR; Craven PA
Metabolism; 1976 Oct; 25(10):1113-27. PubMed ID: 184365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
